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Paffeine Decreases
xercise-Induced Myocardial Flow Reserve
ehdi Namdar, MD,* Pascal Koepfli, MD,* Renate Grathwohl, MD,* Patrick T. Siegrist, MD,*
ichael Klainguti, MD,* Tiziano Schepis, MD,* Raphael Delaloye, MD,* Christophe A. Wyss, MD,*
amuel P. Fleischmann, MD,* Oliver Gaemperli, MD,* Philipp A. Kaufmann, MD*†
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OBJECTIVES We studied the acute effect of caffeine on myocardial blood flow (MBF) at rest and exercise
in healthy volunteers at normoxia and during acute exposure to simulated altitude.
BACKGROUND Caffeine is a widely consumed stimulant, although its cardiovascular safety remains contro-
versial and its effect on MBF is unknown.
METHODS 15O-labeled H2O and positron emission tomography (PET) were used to measure regional
MBF at rest and immediately after supine bicycle exercise in healthy volunteers at normoxia
(n  10; mean workload, 175 W; 98% predicted; mean age, 27  6 years) as well as during
hypoxia, simulating an altitude of 4,500 m by inhalation of a mixture of 12.5% oxygen (n 
8; 148 W; 78% predicted; mean age, 29 4 years). Measurements were repeated 50 min after
oral ingestion of caffeine (200 mg). Myocardial flow reserve (MFR) was calculated as the ratio
of hyperemic to resting MBF.
RESULTS Resting MBF was not affected by caffeine at normoxia (1.05 0.36 ml/min/g vs. 1.17 0.27
ml/min/g; p NS), although it was significantly increased at hypoxia (1.71 0.41 ml/min/g
vs. 2.22  0.49 ml/min/g; p  0.001). By contrast, exercise-induced hyperemic MBF
decreased significantly at normoxia (2.51  0.58 ml/min/g vs. 2.15  0.47 ml/min/g; p 
0.05) and hypoxia (5.15  0.79 ml/min/g vs. 3.98  0.83 ml/min/g; p  0.005 vs. baseline;
p  0.005 vs. normoxia). The MFR decreased by 22% at normoxia (2.53  0.69 to 1.90 
0.49; p  0.01) and by 39% at hypoxia (3.13  0.60 to 1.87  0.45, p  0.005; p  0.05
vs. normoxia).
CONCLUSIONS In healthy volunteers, a caffeine dose corresponding to two cups of coffee (200 mg)
significantly decreased exercise-induced MFR at normoxia and was even more pronounced
during exposure to altitude. (J Am Coll Cardiol 2006;47:405–10) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.064College of Cardiology Foundation
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secause coffee is consumed in large amounts all over the
orld (1), characterization of its cardiac effects in people is
mportant. Coffee drinking has been associated with in-
reased cardiovascular morbidity and mortality in some
2–4) but not all (5) prospective and epidemiological stud-
es, whereas a recent trial found a beneficial effect of coffee
6). Similarly, the role of coffee in the development of
ardiovascular risk factors is controversial. Coffee drinking
as been linked to both elevated (7) and reduced (8) but also
o unchanged blood pressure (9) and serum cholesterol
evels (10), depending on the brewing method (11).
The influence of caffeine on myocardial blood flow
MBF) during physical stress is largely unknown. Caffeine
ight directly affect MBF by blocking coronary adenosine
2 receptors (12) or, indirectly, via catecholamine release
ausing alpha-2 receptor-mediated coronary vasomotion
7). Because coffee consumption has been found to blunt
ipyridamole-induced hyperemia via adenosine A2 receptor
ntagonism (13), caffeinated foods or beverages must be
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he †Center for Integrative Human Physiology (CIHP), University of Zurich, Zurich,
witzerland. Dr. Kaufmann was supported by a grant from the Swiss National Science
oundation (SNSF-professorship grant no. PP00A-68835 and grant no. 31-68386).d
Manuscript received July 3, 2005; revised manuscript received August 2, 2005,
ccepted August 16, 2005.voided before pharmacologic radionuclide stress perfusion
maging. Nothing is known, however, about the impact of
affeine on exercise-induced hyperemia. Although during
xercise extravascular resistive forces (14) might in part
ounteract adenosine-mediated metabolic vasodilation, hy-
eremic response to exercise may largely depend on intrinsic
denosine production (15). Because adenosine is released by
yocytes inversely related to myocardial oxygen tension to
ct via adenosine receptors on coronary vascular smooth
uscle cells to induce coronary vasodilation, this mecha-
ism might be susceptible to adenosine receptor antagonism
y caffeine. This could be even more pronounced during
tates of decreased oxygen delivery because adenosine pro-
uction is linked to myocardial partial oxygen tension (pO2)
16) and the major stimulus for adenosine production seems
o be an imbalance between oxygen delivery and oxygen
emand.
Thus, the goals of the present study were: 1) to assess the
ffect of caffeine on resting and exercise-induced hyperemic
BF and on the resulting myocardial flow reserve (MFR),
nd 2) to study the impact of caffeine on exercise-induced
BF during simulated hypoxia mimicking comparable
tates of oxygen deprivation in ischemic coronary artery
isease (CAD) (17).
MS
1
h
N
p
c
b
S
y
(
M
e
4
w
m
u
f
d
c
o
s
F
p
s
2
a
s
s
A
i
m
(
m
s
(
a
e
e
a
a
a
n
r
c
I
i
o
d
e
r
c
r
I
C
A
t
t
m
a
5
I
f
(
s
t
S
(
a
i
s
d
t
i
i
w
m
m
C
a
a
c
M
h
c
S
s
d
p
s
m
r
b
(
g
R
A
a
H
406 Namdar et al. JACC Vol. 47, No. 2, 2006
Caffeine Decreases Myocardial Flow Reserve January 17, 2006:405–10ETHODS
tudy population. Eighteen healthy volunteers (7 women,
1 men) were included in the study. The patients had no
istory of and low clinical probability for CAD (18).
ormal lipid profiles were found in each individual. All
atients were habitual coffee drinkers (at least two cups of
offee per day) but refrained from ingesting caffeinated
everages or food for 36 h before the study.
tudy protocol. For group 1 (n  10; mean age, 27  6
ears), with the patient’s feet attached to a bicycle ergometer
model 380 B, Siemens-Elema AG, Bulach, Switzerland),
BF was measured at rest and during supine bicycle
xercise-induced hyperemia at normoxia corresponding to
50 m above sea level (i.e., Zurich ground altitude). Exercise
as started at 60 W, and workload was increased every
inute to reach after five minutes the predicted value for
pright bicycle exercise. The MBF measurement was per-
ormed immediately after the end of exercise as recently
ocumented (19). This was followed by oral intake of a
ommercially available tablet containing 200 mg caffeine as
nly active substance (GlaxoSmithKline, Pittsburgh, Penn-
ylvania), a dose corresponding to two cups of coffee (7).
ifty minutes later at the time of expected serum caffeine
eak level (7,20), the measurements were repeated using the
ame protocol used at baseline. During the 50-min break, a
0-min transmission scan was acquired for the purpose of
ttenuation correction of all emission scans.
Group 2 (n  8; mean age, 29  4 years) underwent the
ame study protocol as group 1 while exposed to a hypoxia
imulating an altitude of 4,500 m throughout the study.
ltitude simulation (hypoxic hypoxia) was achieved by
nhalation of moistened hypoxic gas mixture (through a
outhpiece) consisting of approximately 12.5% oxygen
O2) in nitrogen (N2), resulting in an oxygen pressure of 90
m Hg (17,21). Heart rate and peripheral arterial oxygen
aturation (SaO2) were recorded with a finger pulse oximeter
Nellcor N-200E, Nellcor Inc., Hayward, California). After
chieving a cardiorespiratory steady state as assessed by a steady
nd-tidal CO2 partial pressure, SaO2, and heart rate, positron
mission tomography (PET) measurements were performed
s previously reported (17,21). Exercise was started at 60 W,
nd workload was increased every minute to target the same
verage rate-pressure product (RPP) values as found at
ormoxia to allow meaningful comparison as previously
eported (17). During the examination, blood pressure was
ontinuously monitored by a Finapress BP Monitor (BOC
Abbreviations and Acronyms
CAD  coronary artery disease
MBF  myocardial blood flow
MFR  myocardial flow reserve
PET  positron emission tomography
RPP  rate-pressure productnc., Englewood, Colorado) and recorded at one-minute pntervals. The electrocardiogram was monitored continu-
usly throughout the procedure, and a 12-lead electrocar-
iogram was recorded at baseline and every minute during
xercise at each level as well as during five minutes of
ecovery. Venous blood samples to determine serum caffeine
oncentration and lipid values were drawn before baseline
esting scan and before post-caffeine bicycle exercise.
mage acquisition. The MBF was assessed at the PET
enter of the University Hospital in Zurich on a GE
dvance positron emission tomograph (GE Medical Sys-
ems, Milwaukee, Wisconsin). An intravenous bolus of 500
o 700 MBq 15O-water was infused over 20 s at a rate of 10
l/min to assess MBF. The line was then flushed for
nother 2 min. The dynamic image sequences were: 14 
s, 3  10 s, 3  20 s, and 4  30 s.
mage processing. The obtained sinograms were corrected
or attenuation and reconstructed on a Sun workstation
Sun Microsystems, Mountain View, California) using
tandard reconstruction algorithms. Images were transferred
o a Transtec 2200 PC (Transtec Computer AG, Bulach,
witzerland) and analyzed with the pmod software package
PMOD Technologies Ltd., Zurich, Switzerland) designed
nd validated at our institution (19,22,23) using myocardial
mages generated directly from the dynamic 15O-water
tudy by means of linear dimension reduction of the
ynamic sinograms. Regions of interest were drawn within
he left ventricular cavity and myocardium on consecutive
mage planes and projected onto the dynamic 15O-water
mages to generate blood time-activity curves. These curves
ere fitted to a single tissue compartment tracer kinetic
odel to give values of regional and global MBF (ml/
in/g) (24–26).
oronary resistance and MFR. To account for the vari-
bility of coronary driving pressure, the ratio of mean
rterial pressure to MBF was calculated as an index of
oronary resistance as previously described (25,26). The
FR was defined as the ratio of MBF during physiologic
yperemia (induced by exercise) to MBF at rest and was
alculated for baseline and repeated measurements.
tatistical analysis. Data are reported as mean values 
tandard deviation. Hemodynamic and PET data at rest and
uring stress were compared using the paired Student t test;
values of 0.05 were considered to indicate statistical
ignificance. Based on an expected standard deviation in
inimal coronary resistance of 5 (19), a minimum clinically
elevant difference in minimal coronary resistance of 20%
etween baseline and caffeine, alpha  0.05 and a power
1-beta) of 0.8, the number of patients necessary (in each
roup) was calculated to be fewer than 10.
ESULTS
ll patients tolerated the simulated altitude subjectively well
nd without objective impairment.
emodynamic findings. In both groups, heart rate, blood
ressure, and RPP were not affected by caffeine, neither at
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January 17, 2006:405–10 Caffeine Decreases Myocardial Flow Reserveest nor at peak exercise (Table 1). This holds true also for
he post-exercise period during MBF measurement in group
(RPP baseline, 11,868  1,933 vs. caffeine, 13,073 
,534; p  NS) and group 2 (RPP, 12,827  2,350 vs.
2,361 1,890, p NS). In group 1, 98% ( 175 W), and
n group 2, 78% ( 148 W) of the predicted maximum
orkload was achieved.
erum caffeine and lipid levels. At baseline, caffeine level
veraged 0.52  1.28 mol/l in 3 patients but was immea-
urably low in 15 patients. Fifty minutes after caffeine
ngestion, serum caffeine was 14.5  8.9 ml/l. Caffeine
ad no influence on total cholesterol (4.4  0.8 mmol/l vs.
.3  0.8 mmol/l; p  NS), nor on low-density lipoprotein
2.4  0.7 mmol/l vs. 2.5  0.7 mmol/l; p  NS), nor
igh-density lipoprotein levels (1.5  0.5 mmol/l vs. 1.4 
.3 mmol/l; p  NS).
espiratory parameters. There was a significant hypoxic
yperventilation in patients at 4,500 m with a decrease in
nd-tidal CO2 partial pressure from 36  2 mm Hg to 33 
mm Hg (p  0.01). Exercise induced an increase in
espiratory frequency (p  0.01). Respiratory frequency
uring hypoxia was not affected by caffeine, neither at rest
15 3 breaths/min at baseline vs. 14 1 breaths/min after
affeine, p  NS) nor during exercise (23  6 breaths/min
s. 24  5 breaths/min, p  NS).
able 1. Hemodynamics
Normoxia
Baseline Caffei
est
SBP (mm Hg) 124  12 120 
DBP (mm Hg) 73  10 71 
MAP (mm Hg) 107  10 104 
HR (beats/min) 66  13 65 
RPP (mm Hg  beats/min) 8,179  1,933 7,771 
eak exercise
SBP (mm Hg) 152  21 159 
DBP (mm Hg) 90  9 95 
MAP (mm Hg) 152  8 156 
HR (beats/min) 153  4 154 
RPP (mm Hg  beats/min) 23,173  3,487 24,382 
BP  diastolic blood pressure; HR  heart rate; MAP  mean blood pressure; RFigure 1. Individual values for myocardial blood flow (MBF) at rBF and MFR. GROUP 1 (NORMOXIA). Mean resting
BF showed a non-significant trend to increase (p  0.14)
fter caffeine ingestion, whereas bicycle exercise-induced
yperemic MBF decreased significantly by 13% (p  0.05)
Figs. 1 and 2), resulting in a decrease in physiological
bicycle exercise-induced) MFR of 22% from 2.53 0.69 to
.90  0.49 (p  0.01) (Fig. 3) (Table 2).
ROUP 2 (HYPOXIA). The MBF values during hypoxia were
ignificantly higher than those found in group 1 at nor-
oxia. Mean resting MBF increased significantly after
affeine ingestion (31%, p  0.001), whereas bicycle
xercise-induced hyperemic MBF decreased by 22% (p 
.005) (Table 2). Physiological (bicycle exercise-induced)
FR (Fig. 3) decreased by 39% from 3.13  0.6 to 1.87 
.45 (p  0.005; p  0.05 vs. normoxia).
oronary resistance. GROUP 1 (NORMOXIA). Coronary re-
istance at rest showed a non-significant decrease after
affeine ingestion (110  23 to 98  19; p  NS). After
icycle exercise, resistance decreased significantly compared
ith rest (p  0.001), but was higher after caffeine com-
ared with baseline (46  15 vs. 54  15, p  0.001).
ROUP 2 (HYPOXIA). Coronary resistance was lower during
ypoxia throughout the study compared with normoxia.
affeine further decreased resistance at rest from 68 18 to
Hypoxia
p Baseline Caffeine p
NS 129  12 125  16 NS
NS 69  8 70  11 NS
NS 109  10 104  14 NS
NS 77  11 78  21 NS
NS 9,996  2,265 9,860  3,362 NS
NS 152  11 154  10 NS
NS 88  5 92  6 NS
NS 163  5 161  7 NS
NS 168  9 164  8 NS
NS 25,591  1,774 25,274  2,287 NS
rate pressure product; SBP  systolic blood pressure.ne
11
11
9
11
1,037
19
4
5
8
2,360est and after exercise before and after caffeine consumption.
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Caffeine Decreases Myocardial Flow Reserve January 17, 2006:405–109  11 (p  0.005). After bicycle exercise, resistance was
ignificantly decreased compared with rest (p  0.001), but
as higher after caffeine compared with baseline (20 5 vs.
8  7, p  0.005).
ISCUSSION
affeine decreases exercise-induced hyperemic MBF, re-
ulting in a significant decrease in physiologic MFR. This is
ignificantly more pronounced at high-altitude exposure,
here resting flow significantly increases and hyperemic
ow response is blunted significantly more by caffeine than
t normoxia. Although the long-term effect of caffeine
onsumption on human health is the subject of an ongoing
ontroversy (27,28), we have studied the acute impact of
affeine consumption on MBF and found no significant
ncrease in resting MBF by caffeine during normoxia, in
greement with Bottcher et al. (13). By contrast, at hyp-
xia—with which resting MBF was higher than at nor-
oxia, in line with our previous results (21)—we found an
ncrease in resting MBF after caffeine. This may in part be
xplained by the fact that caffeine might stimulate local and
ystemic catecholamine release (7), adding to the hypoxia-
nduced sympathetic activation, which contributes impor-
antly to the regulation of MBF (29).
Because MBF is mainly determined by cardiac workload
i.e., RPP) at rest and during physical exercise (30), bicycle
xercise workload at altitude (group 2) was stepwise in-
reased to target the same RPP as at normoxia (group 1) to
llow meaningful comparison of the hyperemic MBF re-
ponses between the two groups (17). At hypoxia, target
PP was attained with a significantly lower workload level
han at normoxia because of the hypoxia-induced increase in
ympathetic tone. Nevertheless, exercise-induced hyperemic
igure 2. Changes in myocardial blood flow (MBF) induced by caffeine.
fter caffeine consumption, resting MBF increased at hypoxia but not at
ormoxia, whereas exercise-induced hyperemic flow response was de-
reased in both groups. Caffeine blunted the hyperemic flow significantly
ore pronounced at altitude than at normoxia. Open bars  normoxia;
olid bars  hypoxia. *p  0.05 vs. baseline.ow response at altitude was significantly increased com-
F
cared with normoxia, despite the lower workload. Caffeine
aused an increase in coronary resistance resulting in a
ecrease in exercise-induced hyperemic MBF, which was
ore pronounced during altitude exposure than at nor-
oxia, supporting that compensatory mechanisms of
ypoxia-induced increase in MBF are in part adenosine-
ediated and, thus, susceptible to caffeine. This is in line
ith previous reports in experimental animals in which an
ncrease in MBF after aminophylline infusion has been
ttributed to a stimulation of alpha-1-adrenoreceptors at
aseline conditions (31), whereas during situations with
ncreased adenosine release, the inhibitory effect of ami-
ophylline on adenosine receptors predominated over the
eneficial effects of alpha-1-adrenoreceptor stimulation.
Although we found a significantly increased coronary
esistance and decreased MFR after caffeine consumption,
ur study design does not allow comment on the long-term
ffect of caffeine. Nevertheless, because impairment of
oronary endothelial function (32) and specifically impaired
BF response as assessed by PET (33) have been shown to
e independent predictors of unfavorable cardiovascular
utcome, our results may at least raise questions about safety
n patients with impaired MFR, such as CAD patients.
urthermore, our results support that exercise-induced hy-
eremic flow response may at least in part be antagonized by
affeine, indicating that in people, adenosine seems involved
n the regulation of MBF at exercise. This may suggest that
he advice to refrain from methylxanthine-containing foods
nd beverages before undergoing a radionuclide perfusion
can should not be confined to pharmacological stress (34),
ut could possibly be extended to physical exercise stress.
Although caffeine has been shown to impair pharmaco-
ogically induced hyperemia by adenosine-receptor antago-
ism, no data exist so far on the impact of caffeine on MBF
t exercise, reflecting daily life activity. Therefore, we have used
icycle exercise stress for stimulation of hyperemic MBF.
tudy limitations. A first limitation of this study is that
atients did not exercise at their individual but rather at the
aximal predicted level of effort, however, this was because
xercise workload in the supine position usually matches
pproximately 70% of the workload achieved in the uprightigure 3. Individual myocardial flow reserve (MFR) values before and after
affeine. Caffeine decreased MFR in both groups.
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January 17, 2006:405–10 Caffeine Decreases Myocardial Flow Reserveosition (35,36). In addition, physical capacity at high
ltitudes of 4,500 m has been found to match 70% of the
apacity at sea level (37). Thus, the workload in the present
tudy was reasonably high, because 98% and 78% of the
redicted workload was achieved at normoxia and at hyp-
xia, respectively.
Second, data acquisition was obtained in the immediate
ost-exercise period when the cardiac power output is
onsiderably decreased and when flow is also expected to
ecrease rapidly. Therefore, we assessed the impact of
affeine on an MBF value representing the average value
ver five minutes of recovery, rather than the peak MBF
alue at maximal exercise. These suboptimal conditions
ere chosen as a compromise to avoid excessive motion
rtifact during scanning. However, the fact that every
atient was used as his or her own control strengthens our
esults, and the validity of this method has been recently
ocumented in a repeatability study (19).
Furthermore, no patients with CAD were included,
ecause this would have been beyond the scope of testing
ur hypothesis on the interaction of caffeine and myocardial
erfusion during exercise stress. Certainly, further studies
ill now need to assess the impact of caffeine in CAD
atients.
In summary, our results show that within 50 min, oral
ntake of a common caffeine dose corresponding to two cups
f coffee (200 mg) significantly decreases bicycle exercise-
nduced hyperemic myocardial flow response at normoxia
nd is even more pronounced during exposure to simulated
ltitude. Although these findings seem not to have a clinical
mportance in healthy volunteers, they may raise safety
uestions in patients with reduced MFR as seen in CAD,
articularly before physical exercise and at high-altitude
xposure.
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uclear Cardiology, University Hospital Zurich, Ramistr. 100
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